Sera Prognostics (SERA) Liabilities and Shareholders Equity (2020 - 2026)

Sera Prognostics (SERA) reported Liabilities and Shareholders Equity of $93.5 million for Q1 2026, down 20.85% on a YoY basis from $118.2 million in Q1 2025, and down 8.23% quarter-over-quarter from $101.9 million in Q4 2025.

Sera Prognostics (SERA) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

Sera Prognostics has reported Liabilities and Shareholders Equity for 7 years, with the latest figure at $93.5 million in Q1 2026.

  • For the quarter ending Q1 2026, Liabilities and Shareholders Equity fell 20.85% year-over-year to $93.5 million; the trailing twelve-month figure through Mar 2026 stood at $415.4 million (up 17.15% YoY), and the FY2025 full-year result was $101.9 million, up 40.45% from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 stood at $93.5 million, down from $101.9 million in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $134.9 million in Q1 2022, with the low at $72.6 million in Q4 2024.
  • Historically, Liabilities and Shareholders Equity has averaged $102.4 million across 5 years, with a median of $101.9 million in 2025.
  • Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity slipped 24.16% — and 2025, when it soared 40.45%.
  • Sera Prognostics' Liabilities and Shareholders Equity stood at $116.3 million in 2022, then retreated by 17.96% to $95.4 million in 2023, then retreated by 23.96% to $72.6 million in 2024, then surged by 40.45% to $101.9 million in 2025, then declined by 8.23% to $93.5 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $93.5 million (Q1 2026), $101.9 million (Q4 2025), and $108.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 110.43 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 46.29 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 91.49 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 13.32 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 31.92 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 6.63 Bn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 37.13 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 10.74 Bn
10 Sera Prognostics 93.48 Mn 93.48 Mn -28,000.00 93.54 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 93.54 Mn
Dec 31, 2025 101.93 Mn
Sep 30, 2025 108.13 Mn
Jun 30, 2025 111.83 Mn
Mar 31, 2025 118.18 Mn
Dec 31, 2024 72.58 Mn
Sep 30, 2024 79.00 Mn
Jun 30, 2024 84.86 Mn
Mar 31, 2024 89.89 Mn
Dec 31, 2023 95.44 Mn
Sep 30, 2023 90.06 Mn
Jun 30, 2023 96.68 Mn
Mar 31, 2023 105.61 Mn
Dec 31, 2022 116.33 Mn
Sep 30, 2022 116.56 Mn
Jun 30, 2022 125.06 Mn
Mar 31, 2022 134.87 Mn
Dec 31, 2021 147.03 Mn
Sep 30, 2021 153.69 Mn
Jun 30, 2021 95.07 Mn